Development of NC1 and NC2 domains of Type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients

Journal of Dermatological Science

Volumn 62, Issue 3, 2011, Pages 169-175

  Saleh, Marwah Adly ^a,g   Ishii, Ken ^a,h   Kim, Yool Ja ^b   Murakami, Akihiro ^b   Ishii, Norito ^c   Hashimoto, Takashi ^c   Schmidt, Enno ^d   Zillikens, Detlef ^d   Shirakata, Yuji ^e   Hashimoto, Koji ^e   Kitajima, Yasuo ^f   Amagai, Masayuki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Medical & Biological Laboratories Co Ltd   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF LÜBECK   (Germany)

^e EHIME UNIVERSITY   (Japan)

^f Kizawa Memorial Hospital   (Japan)

^g CAIRO UNIVERSITY   (Egypt)

^h TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

Autoantibodies; ELISA; Epidermolysis bullosa acquisita; Type VII collagen

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; COLCHICINE; COLLAGEN TYPE 7; EPITOPE; MINOCYCLINE; PREDNISOLONE; STEROID;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMAN; NUCLEOTIDE SEQUENCE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; COLLAGEN TYPE VII; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; EPITOPES; HUMANS; IMMUNOGLOBULIN G; MICROSCOPY, FLUORESCENCE; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TIME FACTORS;

EID: 79955882703     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.03.003     Document Type: Article

References (19)

1. Woodley D.T., Briggaman R.A., Okeefe E.J., Inman A.O., Queen L.L., Gammon W.R. Identification of the skin basement-membrane auto-antigen in epidermolysis bullosa-acquisita. N Engl J Med 1984, 310:1007-1013.
2. Woodley D.T., O'Keefe E.J., Reese M.J., Mechanic G.L., Briggaman R.A., Gammon W.R. Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J Invest Dermatol 1986, 86:668-672.
3. Woodley D.T., Chang C., Saadat P., Ram R., Liu Z., Chen M. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005, 124:958-964.
4. Woodley D.T., Burgeson R.E., Lunstrum G., Bruckner-Tuderman L., Reese M.J., Briggaman R.A. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988, 81:683-687.
5. Remington J., Chen M., Burnett J., Woodley D.T. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Curr Dir Autoimmun 2008, 10:195-205.
6. Burgeson R.E. Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 1993, 101:252-255.
7. Keene D.R., Sakai L.Y., Lunstrum G.P., Morris N.P., Burgeson R.E. Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol 1987, 104:611-621.
8. Sakai L.Y., Keene D.R., Morris N.P., Burgeson R.E. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol 1986, 103:1577-1586.
9. Chen M., Doostan A., Bandyopadhyay P., Remington J., Wang X., Hou Y., et al. The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol 2007, 170:2009-2018.
10. Gammon W.R., Murrell D.F., Jenison M.W., Padilla K.M., Prisayanh P.S., Jones D.A., et al. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J Invest Dermatol 1993, 100:618-622.
11. Ishii N., Yoshida M., Hisamatsu Y., Ishida-Yamamoto A., Nakane H., Iizuka H., et al. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol 2004, 150:843-851.
12. Chen M., Keene D.R., Costa F.K., Tahk S.H., Woodley D.T. The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis bullosa acquisita autoantibodies. J Biol Chem 2001, 276:21649-21655.
13. Mayuzumi M., Akiyama M., Nishie W., Ukae S., Abe M., Sawamura D., et al. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature. Br J Dermatol 2006, 155:1048-1052.
14. Ishii N., Yoshida M., Ishida-Yamamoto A., Fritsch A., Elfert S., Bruckner-Tuderman L., et al. Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy. Br J Dermatol 2009, 160:1090-1093.
15. Fukumoto T., Umekawa T., Higuchi M., Hashimoto T., Shumann H., Bruckner-Tuderman L., et al. Childhood epidermolysis bullosa acquisita with autoantibodies against all 3 structural domains of type VII collagen. J Am Acad Dermatol 2004, 50:480-482.
16. Gammon W.R., Kowalewski C., Chorzelski T.P., Kumar V., Briggaman R.A., Beutner E.H. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 1990, 22:664-670.
17. Chen M., Chan L.S., Cai X., O'Toole E.A., Sample J.C., Woodley D.T. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997, 108:68-72.
18. Bruckner-Tuderman L., Nilssen O., Zimmermann D.R., Dours-Zimmermann M.T., Kalinke D.U., Gedde-Dahl T., et al. Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J Cell Biol 1995, 131:551-559.
19. Rosenbach M., Murrell D.F., Bystryn J.C., Dulay S., Dick S., Fakharzadeh S., et al. Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol 2009, 129:2404-2410.